08:57 AM EDT, 03/19/2026 (MT Newswires) -- Health care stocks were leaning lower pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) declining by 0.4% and the iShares Biotechnology ETF (IBB) down 0.5%.

Novo Nordisk ( NVO ) is looking to expand access to obesity treatments, like GLP-1 drugs, in Japan by targeting self-funded patients, Bloomberg News reported, citing a company executive. Shares of Novo Nordisk ( NVO ) were down more than 3% premarket.